Glucocorticoids inhibit vascular endothelial growth factor expression in growth plate chondrocytes

Molecular and Cellular Endocrinology

Volumn 197, Issue 1-2, 2002, Pages 35-44

  Koedam, Joost A ^a   Smink, Jeske J ^a   Van Buul Offers, Sylvia C ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Chondrocyte; Dexamethasone; Glucocorticoid; Growth plate; Porcine; Vascular endothelial growth factor

Indexed keywords

AGGRECAN; COLLAGEN TYPE 2; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; HYDROCORTISONE; ISOPROTEIN; MESSENGER RNA; ORG 34116; PREDNISOLONE; RAP PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; SIGNAL PEPTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, HUMAN; VASCULOTROPIN A;

ANIMAL CELL; ARTICLE; BLOOD VESSEL; BONE GROWTH; CARTILAGE CELL; CELL CULTURE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG INHIBITION; ENCHONDRAL OSSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GROWTH PLATE; NEWBORN; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SWINE; TIBIA; WESTERN BLOTTING; ANIMAL; BONE DEVELOPMENT; CYTOLOGY; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; ANIMALS, NEWBORN; BONE DEVELOPMENT; CELLS, CULTURED; CHONDROCYTES; DEXAMETHASONE; ENDOTHELIAL GROWTH FACTORS; GLUCOCORTICOIDS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; PROTEIN ISOFORMS; RNA, MESSENGER; SWINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037195522     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(02)00276-9     Document Type: Article

References (49)

1. Abad V., Uyeda J.A., Temple H.T., De Luca F., Baron J. Determinants of spatial polarity in the growth plate. Endocrinology. 140:1999;958-962.
2. Alini M., Marriott A., Chen T., Abe S., Poole A.R. A novel angiogenic molecule produced at the time of chondrocyte hypertrophy during endochondral bone formation. Dev. Biol. 176:1996;124-132.
3. Allen D.B. Growth suppression by glucocorticoid therapy. Endocrinol. Metab. Clin. North Am. 25:1996;699-717.
4. Baron J., Huang Z., Oerter K.E., Bacher J.D., Cutler G.B. Jr. Dexamethasone acts locally to inhibit longitudinal bone growth in rabbits. Am. J. Physiol. 263:1992;E489-E492.
5. Baron J., Klein K.O., Colli M.J., Yanovski J.A., Novosad J.A., Bacher J.D., Bolander M.E., Cutler G.B. Induction of growth plate cartilage ossification by basic fibroblast growth factor. Endocrinology. 35:1994;2790-2793.
6. Bermont L., Lamielle F., Fauconnet S., Esumi H., Weisz A., Adessi G.L. Regulation of vascular endothelial growth factor expression by insulin-like growth factor-I in endometrial adenocarcinoma cells. Int. J. Cancer. 85:2000;117-123.
7. Blodgett F.M., Burgin L., Iezzoni D., Gribetz D., Talbot N.B. Effects of prolonged cortisone therapy on the statural growth, skeletal maturation and metabolic status of children. N. Engl. J. Med. 254:1956;636-641.
8. Carlevaro M.F., Albini A., Ribatti D., Gentili C., Benelli R., Cermelli S., Cancedda R., Cancedda F.D. Transferrin promotes endothelial cell migration and invasion: implication in cartilage neovascularization. J. Cell Biol. 136:1997;1375-1384.
9. Carlevaro M.F., Cermelli S., Cancedda R., Cancedda F.D. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J. Cell Sci. 113:2000;59-69.
10. Claffey K.P., Shih S.-C., Mullen A., Dziennis S., Cusick J.L., Abrams K.R., Lee S.W., Detmar M. Identification of a human VPF/VEGF 3′-untranslated region mediating hypoxia-induced mRNA stability. Mol. Biol. Cell. 9:1998;469-481.
11. Colnot C.I., Helms J.A. A molecular analysis of matrix remodeling and angiogenesis during long bone development. Mech. Dev. 100:2001;245-250.
12. Cullinan-Bove K., Koos R.D. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology. 133:1993;829-837.
13. Dibbens J.A., Miller D.L., Damert A., Risau W., Vadas M.A., Goodall G.J. Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements. Mol. Biol. Cell. 10:1999;907-919.
14. Dietz U.H., Sandell L.J. Cloning of a retinoic acid-sensitive mRNA expressed in cartilage and during chondrogenesis. J. Biol. Chem. 271:1996;3311-3316.
15. Fischer S., Renz D., Schaper W., Karliczek G.F. In vitro effects of dexamethasone on hypoxia-induced hyperpermeability and expression of vascular endothelial growth factor. Eur. J. Pharmacol. 411:2001;231-243.
16. Garcia-Ramirez M., Toran N., Andaluz P., Carrascosa A., Audi L. Vascular endothelial growth factor is expressed in human fetal growth cartilage. J. Bone Miner. Res. 15:2000;534-540.
17. Gerber H.-P., Vu T.H., Ryan A.M., Kowalski J., Werb Z., Ferrera N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nature Med. 5:1999;623-628.
18. Gloddek J., Pagotto U., Paez Pereda M., Arzt A., Stalla G.K., Renner U. Pituitary adenylate cyclase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells. J. Endocrinol. 160:1999;483-490.
19. Goad D.L., Rubin J., Wang H., Tashian A.H. Jr., Patterson C. Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor I. Endocrinology. 137:1996;2262-2268.
20. Heiss J.D., Papavassiliou E., Merrill M.J., Nieman L., Knightly J.J., Walbridge S., Edwards N.A., Oldfield E.H. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats: involvement of the glucocorticoid receptor and vascular permeability factor. J. Clin. Invest. 98:1996;1400-1408.
21. Horner A., Bishop N.J., Bord S., Beeton C., Kelsall A.W., Coleman N., Compston J.E. Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage. J. Anat. 194:1999;519-524.
22. Houck K.A., Ferrara N., Winer J., Cachianes G., Li B., Leung D.W. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 5:1991;1806-1814.
23. Jux C., Leiber K., Hügel U., Blum W., Ohlsson C., Klaus G., Mehls O. Dexamethasone impairs growth hormone (GH)-stimulated growth by suppression of local insulin-like growth factor (IGF)-I production and expression of GH- and IGF-I-receptor in cultured rat chondrocytes. Endocrinology. 139:1998;3296-3305.
24. 2+ currents. Eur. J. Pharmacol. 339:1997;17-26.
25. Koedam J.A., Hoogerbrugge C.M., van Buul-Offers S.C. Differential regulation of IGF-binding proteins in rabbit costal chondrocytes by IGF-I and dexamethasone. J. Endocrinol. 165:2000;557-567.
26. Machein M.R., Kullmer J., Rönicke V., Machein U., Krieg M., Damert A., Breier G., Risau W., Plate K.H. Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells. Neuropathol. Appl. Neurobiol. 25:1999;104-112.
27. Malter J.S. Identification of an AUUUA-specific messenger RNA binding protein. Science. 246:1989;664-666.
28. Manelli F., Giustina A. Glucocorticoid-induced osteoporosis. Trends Endocrinol. Metab. 11:2000;79-85.
29. Miele C., Rochford J.J., Filippa N., Giorgetti-Peraldi S., Van Obberghen E. Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways. J. Biol. Chem. 275:2000;21695-21702.
30. Nauck M., Karakiulakis G., Perruchoud A.P., Papakonstantinou E., Roth M. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur. J. Pharmacol. 341:1998;309-315.
31. Peppel K., Vinci J.M., Baglioni C. The AU-rich sequences in the 3′ untranslated region mediate the increased turnover of interferon mRNA induced by glucocorticoids. J. Exp. Med. 173:1991;349-355.
32. Reinecke M., Schmid A.C., Heiberger-Meyer B., Hunziker E.B., Zapf J. Effect of growth hormone and insulin-like growth factor I (IGF-I) on the expression of IGF-I messenger ribonucleic acid and peptide in rat tibial growth plate and articular chondrocytes in vivo. Endocrinology. 141:1999;2847-2853.
33. Rooman R., Koster J.G., Bloemen R., Gresnigt R., van Buul-Offers S.C. The effect of dexamethasone on body and organ growth of normal and IGF-II transgenic mice. J. Endocrinol. 163:1999;543-552.
34. Ruohola J.K., Valve E.M., Karkkainen M.J., Joukov V., Alitalo K., Härkönen P.L. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Mol. Cell. Endocrinol. 149:1999;29-40.
35. Saadeh P.B., Mehrara B.J., Steinbrech D.S., Spector J.A., Greenwald J.A., Chin G.S., Ueno H., Gittes G.K., Longaker M.T. Mechanism of fibroblast growth factor-2 modulation of vascular endothelial growth factor expression by osteoblastic cells. Endocrinology. 141:2000;2075-2083.
36. Schipani E., Ryan H.E., Didrckson S., Kobayashi T., Knight M., Johnson R.S. Hypoxia in cartilage: HIF-1α is essential for chondrocyte growth arrest and survival. Genes Dev. 15:2001;2865-2876.
37. Schüle R., Rangarajan P., Kliewer S., Ransone L.J., Bolado J., Yang N., Verma I.M., Evans R.M. Functional antagonism between oncoprotein c-Jun and glucocorticoid receptor. Cell. 62:1990;1217-1226.
38. Semenza G.L. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol. Med. 7:2001;345-350.
39. Shapiro I.M., Mansfield K.D., Evans S.M., Lord E.M., Koch C.J. Chondrocytes in the endochondral growth plate cartilage are not hypoxic. Am. J. Physiol. 272:1997;C1134-C1143.
40. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 359:1992;843-845.
41. Silvestrini G., Mocetti P., Ballanti P., DiGrezia R., Bonucci E. Cytochemical demonstration of the glucocorticoid receptor in skeletal cells of the rat. Endocr. Res. 25:1999;117-128.
42. Smink J.J., Koedam J.A., Koster J.G., van Buul-Offers S.C. Dexamethasone-induced growth inhibition of porcine growth plate chondrocytes is accompanied by changes in levels of IGF axis components. J. Endocrinol. 174:2002;343-352.
43. Smink, J.J., Koster, J.G., Gresnigt, M.G., Rooman, R., Koedam, J.A., van Buul-Offers, S.C., 2002b. IGF and IGF-binding protein expression in the growth plate of normal, dexamethasone-treated and human IGF-II transgenic mice. J. Endocrinology (in press).
44. Stevens D.A., Williams G.R. Hormone regulation of chondrocyte differentiation and endochondral bone formation. Mol. Cell. Endocrinol. 151:1999;195-204.
45. Tischer E., Mitchell R., Hartman T., Silva M., Gospodarowicz D., Fiddes J.C., Abraham J.A. The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266:1991;11947-11954.
46. Warren R.S., Yuan H., Matli M.R., Ferrara N., Donner D.B. Induction of vascular endothelial growth factor by insulin-like growth factor I in colorectal carcinoma. J. Biol. Chem. 271:1996;29483-29488.
47. Webster J.C., Cidlowski J.A. Mechanism of glucocorticoid-receptor-mediated repression of gene expression. Trends Endocrinol. Metab. 10:1999;396-402.
48. Weindel K., Marmé D., Weich H.A. AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor. Biochem. Biophys. Res. Commun. 183:1992;1167-1174.
49. Yeh L.-C.C., Lee J.C. Osteogenic protein-1 increases gene expression of vascular endothelial growth factor in primary cultures of fetal rat calvaria cells. Mol. Cell. Endocrinol. 153:1999;113-124.